Praxis Precision Medicines Statistics
Want to see PRAX full AI Analyst Report?
Praxis Precision Medicines (PRAX) Stock Statistics & Valuation Metrics
Total Valuation
Praxis Precision Medicines has a market cap or net worth of $9.44B. The enterprise value is $7.75B.
- Market Cap
- $9.44B
- Enterprise Value
- $7.75B
Share Statistics
Praxis Precision Medicines has 27,951,553 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 27,951,553
- Owned by Insiders
- 0.68%
- Owned by Institutions
- 52.06%
Financial Efficiency
Praxis Precision Medicines’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -37.14%.
- Return on Equity (ROE)
- -0.35
- Return on Assets (ROA)
- -0.32
- Return on Invested Capital (ROIC)
- -37.14%
- Return on Capital Employed (ROCE)
- -0.37
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.81M
- Employee Count
- 168
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Praxis Precision Medicines is -27.01. Praxis Precision Medicines’s PEG ratio is -90.74.
- PE Ratio
- -27.01
- PS Ratio
- 0.00
- PB Ratio
- 8.02
- Price to FCF
- -29.85
- Price to Operating Cash Flow
- -31.31
- PEG Ratio
- -90.74
Income Statement
In the last 12 months, Praxis Precision Medicines had revenue of 0 and earned -303.27M in profits. Earnings per share was -13.48.
- Revenue
- 0
- Gross Profit
- -140.00K
- Operating Income
- -326.20M
- Pretax Income
- -303.27M
- Net Income
- -303.27M
- EBITDA
- -303.13M
- Earnings Per Share (EPS)
- -13.48
Cash Flow
In the last 12 months, operating cash flow was -322.69M and capital expenditures -1.09M, giving a free cash flow of -323.78M billion.
- Operating Cash Flow
- -322.69M
- Free Cash Flow
- -323.78M
- Free Cash Flow per Share
- -11.10
Dividends & Yields
Praxis Precision Medicines pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.35%
- Earnings Yield
- -3.56%
Stock Price Statistics
- Beta
- 2.25
- 52-Week Price Change
- 88.61%
- 50-Day Moving Average
- 291.87
- 200-Day Moving Average
- 314.29
- Relative Strength Index (RSI)
- 69.42
- Average Volume (3m)
- 449.05K
Important Dates
Praxis Precision Medicines upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Praxis Precision Medicines as a current ratio of 10.22, with Debt / Equity ratio of 0.01%
- Current Ratio
- 10.22
- Quick Ratio
- 10.22
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.18
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Praxis Precision Medicines has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Praxis Precision Medicines EV to EBITDA ratio is -25.90, with an EV/FCF ratio of -28.74.
- EV to Sales
- 0.00
- EV to EBITDA
- -25.90
- EV to Free Cash Flow
- -28.74
- EV to Operating Cash Flow
- -28.84
Balance Sheet
Praxis Precision Medicines has $745.32M in cash and marketable securities with $732.00K in debt, giving a net cash position of $744.59M billion.
- Cash & Marketable Securities
- $745.32M
- Total Debt
- $732.00K
- Net Cash
- $744.59M
- Net Cash Per Share
- $26.64
- Tangible Book Value Per Share
- $43.17
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Praxis Precision Medicines is $728.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $728.33
- Price Target Upside
- 110.37% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 12
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- 0.75%
Scores
- Smart Score
- 6
- AI Score
- 68
